Market Intelligence and Reports

Explore the dynamic world of cell and gene therapy deal-making with Kalorama Information’s comprehensive report, Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023. This report tracks the deal-making activities in cell and gene therapy since 2021, providing insightful graphs of quarterly trends from 2021-2023 and detailing…

Description:

Out-of-pocket (OOP) healthcare expenses in the United States are on the rise due to various demographic, business, and government trends. Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition delves into these trends, focusing on the financial aspects of OOP spending growth. It provides forecasts of total expenditures…

The Market for Rx-to-OTC Switches, 8th Edition provides an in-depth analysis of the dynamic U.S. Rx-to-OTC switch market, which has grown into a double-digit multi-billion-dollar industry driven by patent expirations, increased competitiveness, FDA collaboration, brand reinvention, consumer demand, and cost containment strategies.

 

Report Highlights:

• Market Dynamics:
  • Examination of the transition of over…

The cell and gene therapy (CGT) sector has experienced remarkable growth, with funding reaching $70 billion in 2021. As barriers to entry lower and the number of approved therapies with proven track records increases, over a thousand companies have entered or expanded within this dynamic field. Keeping up with this rapidly evolving industry is essential,…

Rising out-of-pocket (OOP) healthcare expenses in the United States are driven by a variety of demographic, business, and government trends. Kalorama Information’s report, Out-of-Pocket (OOP) Healthcare Expenditures in the United States, 5th Edition, delves deeply into these trends, focusing on the financial aspects of OOP spending growth and providing forecasts for total expenditures and specialized…

The chemical industry, sandwiched downstream of oil & gas and upstream of pharmaceuticals, foods, and other manufacturing industries, is the backbone of most industrial processes, providing the key raw materials needed for the vast majority of end-use consumer products. Encompassing commodity chemicals, specialty chemicals, and fine chemicals, laboratories within this industry comprise about 5% of…

Environmental testing is a key area of the global analytical instrumentation market that looks at qualitatively and/or quantitatively analyzing contaminants in the environment. These contaminants can take many forms, from toxic chemicals in drinking water as the result of industrial processes to small particulate matter in the air we breathe. In order to protect from…

The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.

Updated June 2020 to reflect the COVID-19 and related lab closure situation.

This report provides detailed data on every major life science and analytical instrument technology…

The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. Unlike small molecule drugs, these biomolecule-based therapeutics, or biologics, are produced using living cells in two distinct phases, called upstream and downstream, which necessitates unique manufacturing processes collectively…

Contract research organizations (CROs) are essential partners in the drug development field. As companies in the pharmaceutical and biotechnology industries shift their development pipelines towards more targeted therapies, the cost of development has significantly increased while the patient pool for each drug is smaller. This has resulted in leaner R&D infrastructures and increasing reliance on…

The pharma/bio sector is one of the highest growing markets in the world, driven by innovations that aim to provide better medication and healthcare for mankind. The development and production of these therapeutics is a costly and lengthy process which is highly regulated at all steps. With significant investments required for R&D, manufacturing, and quality…